← Browse by Condition
Medical Condition

cancer of the bile duct

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05849480 Phase 1, Phase 2
Recruiting

A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)

Enrollment
60 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
View Trial →